Currently, isocitrate dehydrogenase (IDH) levels have prognostic value in wild-type IDH gliomas, and 1p/19q gene expression is a potential prognostic marker in 1p/19q non-deletion gliomas [5]. This evidence concerns the gene IDH3A and central nervous system cancer.